Article
Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.
PloS one - 1 Jan 2014
Kaur Harpreet, Jajodia Ajay, Grover Sandeep, Baghel Ruchi, Gupta Meenal, Jain Sanjeev, Kukreti Ritushree
Abstract excerpt
Literature suggests that disease severity and neurotransmitter signaling pathway genes can accurately identify antipsychotic response in schizophrenia patients. However, putative role of signaling molecules has not been tested in schizophrenia patients based on severity of illness, despite its biological plausibility. In the present study we investigated the possible association of polymorphisms from five...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
